Company Description
4D Pharma (NASDAQ: LBPS) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.
LBPS stock has declined 85.2% over the past year.
This page provides a comprehensive overview of LBPS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
4D Pharma (LBPS) stock. Over the past 12 months, the stock has lost 85.2%.
Latest News
4D Pharma has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include conferences, clinical trial, earnings, fda approval. View all LBPS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
LBPS Company Profile & Sector Positioning
4D Pharma (LBPS) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.